Neuland Laboratories Limited (NSE:NEULANDLAB)

Neuland Laboratories Revenue

Neuland Laboratories had revenue of 4.57B INR in the quarter ending September 30, 2026, a decrease of -11.11%. This brings the company's total for the last twelve months to 23.14B, up 50.87% year-over-year. In the fiscal year ending March 31, 2026, Neuland Laboratories had annual revenue of 20.23B with 36.98% growth.

• Revenue (ttm): 23.14B
• Revenue Growth: +50.87%
• P/S Ratio: 10.90
• Revenue / Employee: 10.60M
• Employees: 2,183
• Market Cap: 252.21B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Usa and North America 7.13B 35.3%
• Europe 6.75B 33.4%
• India 4.84B 23.9%
• Rest of The World 1.50B 7.4%

Fiscal year ended Mar 31, 2026 See the full Neuland Laboratories breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	20.23B	5.46B	36.98%
Mar 31, 2025	14.77B	-817.43M	-5.24%
Mar 31, 2024	15.59B	3.67B	30.81%
Mar 31, 2023	11.91B	2.40B	25.20%
Mar 31, 2022	9.52B	147.07M	1.57%

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error